Workpackages

WP 5

WP5 is meant to merge the outcomes of WP2, WP3 and WP4 and create a consensus document to be further discussed in a larger stakeholder setting. The goal is to provide input for the European research programme, i.e. identify the research gaps for public research. A potential impact of this exercise is to strengthen the role of public national research organisations and European research on medicines for children in general.
Setting priorities for a common paediatric research agenda/ identifying topics for research calls
Validating outcomes of study exercises in a multi-disciplinary setting
Reaching consensus among various stakeholders involved in medicines for children R&D

Workpackages team
Workpackage leader: UK, Medical Research Council
dr. Heike Weber

Work package team members
France, INSERM
Italy, ISS
Spain, iSCiii
Poland, CMHI

Deliverables
D 5.1 Preliminary report on opportunities and barriers for collaboration in medicines for children research
D 5.2 Workshop: Setting the research agenda for medicines for children
D 5.3 Consensus document on opportunities and barriers for collaboration in medicines for children research
D 5.4 Consensus document on needed medicines for children research (incl. topics for joined research calls)

Publications
Protocol: Priority Setting for a Common Paediatric Agenda.

European Stakeholder Survey: List of stakeholders invited to participate in priority setting for research agenda.